Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

"Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report" now available at Fast Market Research


Print article Print article
2013-12-29 18:40:42 - New Business market report from MarketLine: "Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report"

Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Rigel Pharmaceuticals, Inc.
* Intelligence on Rigel Pharmaceuticals, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/757143_rigel_pharmaceuticals_inc_swot_strate ..

Highlights:

Rigel Pharmaceuticals (Rigel or 'the company') is a clinical-stage drug development company engaged in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune disorders, as well as muscle disorders. The company operates in the US, where it is headquartered in South San Francisco, California. It employed 157 people as of December 31, 2012. The company recorded revenues of $2.3 million during the financial year ended December 2012 (FY2012), a decrease of 52.6% over FY2011. The operating loss of the company was $99.4 million in FY2012, as compared to an operating loss of $86.4 million during FY2011. The net loss was $98.8 million in FY2012, as compared to a net loss was $86 million in FY2011.

Reasons to Purchase:

* Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Rigel Pharmaceuticals, Inc.'s business structure, strategy and prospects

Partial Table of Contents:

Company Snapshot
Rigel Pharmaceuticals, Inc.: Company Overview
Rigel Pharmaceuticals, Inc.: Overview and Key Facts
Rigel Pharmaceuticals, Inc.: Overview
Rigel Pharmaceuticals, Inc.: Key Facts
Rigel Pharmaceuticals, Inc.: Key Employees
Rigel Pharmaceuticals, Inc.: Key Employee Biographies
Rigel Pharmaceuticals, Inc.: Major Products and Services
Rigel Pharmaceuticals, Inc.: Company History
Rigel Pharmaceuticals, Inc.: Management Statement
Rigel Pharmaceuticals, Inc.: Locations and Subsidiaries
Rigel Pharmaceuticals, Inc.: Key Competitors
Rigel Pharmaceuticals, Inc.: Company Analysis
Rigel Pharmaceuticals, Inc.: Business Description
Rigel Pharmaceuticals, Inc.: SWOT Analysis
Rigel Pharmaceuticals, Inc.: SWOT Overview
Rigel Pharmaceuticals, Inc.: Strengths
Rigel Pharmaceuticals, Inc.: Weaknesses
Rigel Pharmaceuticals, Inc.: Opportunities
Rigel Pharmaceuticals, Inc.: Threats
Rigel Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Rigel Pharmaceuticals, Inc.: Financial Deals Overview
Rigel Pharmaceuticals, Inc.: Targets and Partners
Rigel Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Rigel Pharmaceuticals, Inc.: Advisors
Rigel Pharmaceuticals, Inc.: Top Financial Advisors
Rigel Pharmaceuticals, Inc.: Capital Raising
Rigel Pharmaceuticals, Inc.: Partnership
Rigel Pharmaceuticals, Inc.: Recent Developments
Rigel Pharmaceuticals, Inc.: News and Events Summary
Rigel Pharmaceuticals, Inc.: Contracts
Rigel Pharmaceuticals, Inc.: Financial Performance
Rigel Pharmaceuticals, Inc.: Research & Development
Rigel Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Rigel Pharmaceuticals, Inc.: Key Facts
Table 2: Rigel Pharmaceuticals, Inc.: Key Employees
Table 4: Rigel Pharmaceuticals, Inc.: Key Competitors
Table 5: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 6: Rigel Pharmaceuticals, Inc.: Targets and Partners
Table 7: Rigel Pharmaceuticals, Inc.: Top Deals 2009 - 2013YTD*
Table 8: Rigel Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 9: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 10: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 11: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 12: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 13: Rigel Pharmaceuticals, Inc.: News and Events Summary
Table 14: Rigel Pharmaceuticals, Inc.: Contracts
Table 15: Rigel Pharmaceuticals, Inc.: Financial Performance
Table 16: Rigel Pharmaceuticals, Inc.: Research & Development
Table 17: Rigel Pharmaceuticals, Inc.: Strategy and Operations

List of Figures

Figure 1: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Figure 2: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Figure 3: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Figure 4: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=757143&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com